06/24/21 MILFORD, Mass.–(BUSINESS WIRE)– Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC and President, Bayer Group Greater China. Dr. Flemming Ornskov, Chairman of the Board, said, “We... Read more
BOSTON – June 24, 2021– Today GE (NYSE: GE) announced the appointment of Peter Arduini as president and Chief Executive Officer of GE Healthcare effective January 3, 2022. Arduini will succeed Kieran Murphy who will continue to serve in his current role until the end of 2021 and then he will serve as a strategic... Read more
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter... Read more
WASHINGTON, June 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more
Tokyo, Japan, June 21, 2021 – Rigaku Corporation (“Rigaku”), Japan’s leading manufacturer of X-ray analysis, measurement and testing instruments, announced today that Toshiyuki Ikeda has succeeded Hikaru Shimura as President and CEO of Rigaku. Rigaku Holdings Corporation, the holding company created this year for the Rigaku Group companies, also named Mr. Ikeda as President and Group... Read more
MENLO PARK, Calif., June 11, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock,... Read more
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 240,000 shares of... Read more
MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced the appointment of three new hires to its growing team. Dr. Catherine Ball joins the company as Senior Vice President of Research, Kathleen Lynch joins as Head of Global... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development. “We’re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important... Read more
Danaher Announces Appointment of A. Shane Sanders to Danaher Board WASHINGTON, May 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed A. Shane Sanders to its Board of Directors and to its Audit Committee. This addition expands the size of Danaher’s Board from twelve to thirteen members. Mr. Sanders is currently Senior... Read more